Stock Markets November 19, 2026 12:34 AM

Bernstein highlights three Chinese chip-equipment names as beneficiaries of onshore substitution

Research house gives Outperform ratings and sets CNY price targets for NAURA, AMEC and Piotech as domestic wafer fabrication equipment adoption rises

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn

Bernstein has identified three Chinese domestic semiconductor equipment makers as primary beneficiaries of China’s push to substitute foreign wafer fabrication equipment with locally produced systems. The firm assigned Outperform ratings to NAURA Technology Group, Advanced Micro-Fabrication Equipment Inc China (AMEC) and Piotech, and set CNY price targets of 1,380, 660 and 1,200 respectively, citing product breadth, technology standing and innovation as drivers of share gains.

Bernstein highlights three Chinese chip-equipment names as beneficiaries of onshore substitution
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Bernstein assigned Outperform ratings to NAURA, AMEC and Piotech and set CNY price targets of 1,380, 660 and 1,200 respectively.
  • Research highlights NAURA’s broad equipment portfolio, AMEC’s technology standing and global recognition, and Piotech’s emphasis on deposition and innovation.
  • All three firms are expected to benefit from wafer fabrication equipment domestic substitution in China, with anticipated accelerating market share gains.

Bernstein has singled out three domestic Chinese vendors in the wafer fabrication equipment space as leading investment opportunities amid increased local sourcing by the country's chipmakers. The research firm applied Outperform ratings to all three companies and attached CNY price targets reflecting its view of each firm’s market positioning.


Top-ranked pick: NAURA Technology Group (SZ:002371)

Bernstein placed NAURA Technology Group at the head of its list, assigning a CNY 1,380.00 price target and an Outperform rating. The firm describes NAURA as the domestic leader in wafer fabrication equipment with the most extensive product range among Chinese suppliers.

NAURA’s product offering spans several equipment categories, including Deposition - with PVD and CVD technologies - Dry Etch using ICP systems, Thermo Processes, and Cleaning tools. Bernstein also points to NAURA’s broad customer base, which includes leading logic, DRAM and NAND manufacturers. The research house expects NAURA to capture increasing market share as wafer fabrication equipment domestic substitution in China accelerates.


Second pick: Advanced Micro-Fabrication Equipment Inc China (AMEC) (SS:688012)

AMEC received an Outperform rating and a CNY 660.00 price target from Bernstein. The firm notes AMEC’s primary strength in Dry Etch tools, specifically CCP and ICP systems, while the company is rapidly expanding its presence in Deposition technologies, including ALD, LPCVD and EPI.

Bernstein characterizes AMEC as the domestic wafer fabrication equipment vendor with the best technology and the broadest global recognition among its Chinese peers. As with the other picks, the research house expects AMEC to benefit from domestic substitution trends in China and to register accelerating share gains.


Third pick: Piotech Inc (SS:688072)

Bernstein’s third highlighted company, Piotech, carries an Outperform rating and a CNY 1,200.00 price target. The firm describes Piotech as an emerging domestic wafer fabrication equipment supplier with a primary focus on Deposition technologies, including PECVD, HDPCVD, SACVD and ALD.

In addition to its deposition roadmap, the company is expanding into wafer-to-wafer and chip-to-wafer hybrid bonding equipment aimed at advanced packaging applications. Bernstein notes Piotech’s track record of product innovation as a factor that should position it to gain market share from the anticipated domestic substitution of wafer fabrication equipment in China.


Observations

  • All three firms were given Outperform ratings by Bernstein and cited as likely beneficiaries of China’s move toward locally produced wafer fabrication equipment.
  • Bernstein’s price targets are CNY 1,380.00 for NAURA, CNY 660.00 for AMEC and CNY 1,200.00 for Piotech.
  • Each company is noted for a particular technological focus or breadth: NAURA for its wide product portfolio, AMEC for technology leadership and global recognition, and Piotech for deposition specialization and innovation.

Impacted sectors

  • Semiconductor equipment and capital goods supplying wafer fabrication tools.
  • Chip manufacturing segments including logic, DRAM and NAND due to customer relationships cited for NAURA.
  • Advanced packaging supply chains, given Piotech’s movement into hybrid bonding equipment.

Limitations and caveats

  • Bernstein’s expectations rest on continued wafer fabrication equipment domestic substitution in China and on accelerating share gains for these vendors; the pace and extent of that substitution are underlying assumptions.
  • Claims about technological leadership and global recognition reflect Bernstein’s assessments; how such positioning translates into sustained market share is uncertain.
  • Product expansion efforts, such as Piotech’s move into hybrid bonding for advanced packaging, represent strategic shifts that carry execution risk.

Risks

  • The thesis depends on continued wafer fabrication equipment domestic substitution in China; if substitution slows, expected share gains may not materialize.
  • Bernstein’s characterization of technology leadership and global recognition may not guarantee sustained commercial success or further market penetration.
  • Expansion into new product areas, such as Piotech’s move into wafer-to-wafer and chip-to-wafer hybrid bonding for advanced packaging, carries execution risk and uncertain adoption.

More from Stock Markets

UK Opens Probe into Chinese Robotic Mower Imports After Husqvarna Complaint Nov 19, 2026 UniCredit and German Authorities Agree Key Terms for Commerzbank Takeover Nov 19, 2026 As AI-linked tech stumbles, pockets of Asia draw non-AI capital Nov 19, 2026 Challenger Board Rejects Daiichi Life's A$6.5 Billion Offer, Cites Undervaluation Nov 19, 2026 Interparfums Lays Out 2027 Targets: $1.58 Billion in Sales, $5 EPS Nov 19, 2026